The miRNA 183/182 cluster, which was downregulated in our series, has also been found to be deregulated in medulloblastoma [48] and prostate cancer [49], and the cluster has been shown to inhibit cell proliferation and migration by targeting FGF9 and NTM in Schwann cells [50]. The gene discussed is FGF9; the disease is prostate cancer.